Hem › Kolorektal cancer › Kansas
Kliniska studier för Kolorektal cancer i Kansas
19 studier för Kolorektal cancer söker deltagare vid platser i Kansas.
Städer i Kansas
- Overland Park8 studier
- Kansas City6 studier
- Wichita4 studier
- Topeka3 studier
- Pittsburg3 studier
- Garden City3 studier
Officiell studietext (engelska)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- och 4 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069Family Communications After Genetic Testing
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Mercy Hospital Pittsburg, Pittsburg
- och 1 fler
RekryterarFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT07143487Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Hospital-Westwood Cancer Center, Westwood
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT05803382Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Westwood
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06218914A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Cancer Center of Kansas, Wichita
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06750094A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Cancer Center of Kansas, Wichita
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06662786Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- University of Kansas, Fairway
RekryterarFas 1
Ålder 12 till 120 · Alla kön · Uppdaterad 23 sep. 2026 · NCT04222413Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- The University of Kansas Clinical Research Center, Westwood
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06445062Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- och 1 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT06696768Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Westwood
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT07228832A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Kansas Cancer Center, Kansas City
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 11 aug. 2026 · NCT05592626Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
- och 2 fler
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 31 juli 2026 · NCT05691491Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Cancer Centers of Kansas, Wichita
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 juli 2026 · NCT06937177Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Kansas, Kansas City
RekryterarFas 1/2
Ålder 18 till 90 · Alla kön · Uppdaterad 6 juli 2026 · NCT06710756Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- The University of Kansas Clinical Research Center, Fairway
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 juni 2026 · NCT06607458Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Mercy Hospital Pittsburg, Pittsburg
RekryterarFas 3Friska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 31 mars 2026 · NCT07018869A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- The University of Kansas Cancer Center, Fairway
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 18 mars 2026 · NCT06244771Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- och 6 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT06418204A Study of IBI363 in Subjects with Advanced Solid Malignancies
- University of Kansas Medical Center (KUMC), Fairway
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 19 dec. 2024 · NCT06281678Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.